Elixinol Wellness Future Growth
Future criteria checks 0/6
We currently don't have sufficient analyst coverage to forecast growth and revenue for Elixinol Wellness.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
| Personal Products earnings growth | 13.0% |
| Revenue growth rate | n/a |
| Future return on equity | n/a |
| Analyst coverage | Low |
| Last updated | 29 Sep 2023 |
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2024 | 13 | -7 | -6 | -7 | 1 |
| 12/31/2023 | 8 | -8 | -3 | -3 | N/A |
| 9/30/2023 | 8 | -7 | -3 | -3 | N/A |
| 6/30/2023 | 7 | -7 | -3 | -3 | N/A |
| 3/31/2023 | 7 | -9 | -6 | -6 | N/A |
| 12/31/2022 | 7 | -11 | -8 | -8 | N/A |
| 9/30/2022 | 7 | -12 | -10 | -10 | N/A |
| 6/30/2022 | 8 | -13 | -12 | -11 | N/A |
| 3/31/2022 | 9 | -15 | -13 | -13 | N/A |
| 12/31/2021 | 9 | -17 | -14 | -14 | N/A |
| 9/30/2021 | 11 | -21 | -15 | -15 | N/A |
| 6/30/2021 | 12 | -25 | -16 | -15 | N/A |
| 3/31/2021 | 13 | -65 | -19 | -19 | N/A |
| 12/31/2020 | 15 | -105 | -23 | -23 | N/A |
| 6/30/2020 | 21 | -161 | -42 | -37 | N/A |
| 3/31/2020 | 26 | -121 | -52 | -44 | N/A |
| 12/31/2019 | 31 | -80 | -62 | -51 | N/A |
| 6/30/2019 | 35 | -10 | -43 | -33 | N/A |
| 3/31/2019 | 34 | -5 | -26 | -19 | N/A |
| 12/31/2018 | 32 | 0 | -10 | -5 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if EXL's forecast earnings growth is above the savings rate (2.3%).
Earnings vs Market: Insufficient data to determine if EXL's earnings are forecast to grow faster than the Australian market
High Growth Earnings: Insufficient data to determine if EXL's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: Insufficient data to determine if EXL's revenue is forecast to grow faster than the Australian market.
High Growth Revenue: Insufficient data to determine if EXL's revenue is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if EXL's Return on Equity is forecast to be high in 3 years time